Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Issue: Jul/Aug 2003 - After the Women's Health Initiative Trial
View All Articles in Issue
Page(s): 288-291
Download in electronic PDF format for $75
Abstract: This discussion of Raynaud’s disease focuses on etiology, pathophysiology, clinical manifestations, diagnosis, prognosis, treatment and recommendations. Tables provide information about drugs of choice for treating Raynaud’s disease and/or Raynaud’s phenomenon, nutritional supplements that may safely reduce the severity and frequency of attacks and sample formulations for treating Raynaud’s disease (Nifedipine in PLO Gel, Nitroglycerin 0.2% Ointment, Coenzyme Q10 100 mg-in-Oil Capsules and Zinc, Magnesium, Calcium and Vitamin D3 Oral Liquid).
Related Keywords: Calcium, for the treatment of Raynaud's disease, Coenzyme Q10, for the treatment of Raynaud's disease, Coenzyme Q10 in oil capsules, for the treatment of Raynaud's disease, Lecithin, for the treatment of Raynaud's disease, Magnesium, for the treatment of Raynaud's disease, Nifedipine in Pluronic lecithin organogel, for the treatment of Raynaud's disease, Nitroglycerin 0.2% ointment, for the treatment of Raynaud's disease, Nutritional supplements, for treatment of Raynaud's disease, Raynaud's disease, compounding for, Raynaud's phenomenon, treatment of, Vitamin E, for the treatment of Raynaud's disease, Zinc, for the treatment of Raynaud's disease, Zinc, magnesium, calcium, and vitamin D3 oral liquid, for the treatment of Raynaud's disease